ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancerAlessandra Gennari, Nadia Harbeck, Frédérique Penault‐Llorca et al.|Annals of Oncology|2021Cited by 1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)Fátima Cardoso, Eric P. Winer, Shani Paluch–Shimon et al.|Annals of Oncology|2020Cited by 1.4k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancerDavid Miles, Giulia Bianchi, Joseph Gligorov et al.|Annals of Oncology|2021Cited by 724
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Julie A. Vendrell, Massimo Barberis et al.|European Journal of Cancer|2021Cited by 174
The extracellular domain of Her2 in serum as a biomarker of breast cancerAlexandre Perrier, Mathieu Boissan, Joseph Gligorov et al.|Laboratory Investigation|2018Cited by 88